Wave Life Sciences Ltd (WVE)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current WVE market cap is 1.47B. The company's latest EPS is USD -0.6320 and P/E is -15.14.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 29.64M | 12.9M | 19.67M | -7.34M | 86.3M |
| Operating Income | -18.1M | -34.09M | -35.02M | -63.58M | 25.52M |
| Net Income | -16.26M | -31.56M | -32.92M | -61.78M | 29.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 20.08M | 40.96M | 3.66M | 115.18M | 111.53M |
| Operating Income | -151.32M | -122.48M | -162.71M | -66.12M | -107.17M |
| Net Income | -149.91M | -122.25M | -161.82M | -57.51M | -97.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 274.95M | 235.27M | 208.82M | 358.5M | 352.21M |
| Total Liabilities | 235.32M | 209.88M | 212.3M | 216.86M | 142.69M |
| Total Equity | 39.63M | 25.39M | -3.48M | 141.64M | 209.52M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 279.24M | 207.01M | 146.39M | 274.95M | 352.21M |
| Total Liabilities | 188.59M | 174.51M | 191.48M | 235.32M | 142.69M |
| Total Equity | 90.65M | 32.5M | -45.09M | 39.63M | 209.52M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -19.43M | -33.43M | -60.9M | -107.38M | -151.03M |
| Investing | -1.12M | -417k | -469k | -852k | -938k |
| Financing | 132.53M | 14.51M | 15.16M | 218.91M | 253.89M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -115.98M | -88.99M | -127.78M | -19.43M | -151.03M |
| Investing | -1.34M | -560k | -1.26M | -1.12M | -938k |
| Financing | 154.54M | 55.83M | 67.19M | 132.53M | 253.89M |
| Market Cap | 1.47B |
| Price to Earnings Ratio | -15.14 |
| Price to Sales Ratio | 13.17 |
| Price to Cash Ratio | 4.86 |
| Price to Book Ratio | 7.01 |
| Dividend Yield | - |
| Shares Outstanding | 153.49M |
| Average Volume (1 week) | 639.54k |
| Average Volume (1 Month) | 1.11M |
| 52 Week Change | 54.43% |
| 52 Week High | 16.735 |
| 52 Week Low | 4.25 |
| Spread (Intraday) | 0.98 (9.84%) |
| Company Name | Wave Life Sciences Ltd |
| Address |
8 cross street #10-00����� singapore 018936 |
| Website | https://www.wavelifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
